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This study determined the molecular mechanisms of tocotrienol-rich fraction (TRF) in preventing cellular senescence of human
diploid ﬁbroblasts (HDFs). Primary culture of HDFs at various passages were incubated with 0.5mg/mL TRF for 24 h. Telomere
shortening with decreased telomerase activity was observed in senescent HDFs while the levels of damaged DNA and number of
cells in G0/G1 phase were increased and S phase cells were decreased. Incubation with TRF reversed the morphology of senescent
HDFs to resemble that of young cells with decreased activity of SA-β-gal, damaged DNA, and cells in G0/G1 phase while cells in the
S phase were increased. Elongated telomere length and restoration of telomerase activity were observed in TRF-treated senescent
HDFs. These ﬁndings conﬁrmed the ability of tocotrienol-rich fraction in preventing HDFs cellular ageing by restoring telomere
length and telomerase activity, reducing damaged DNA, and reversing cell cycle arrest associated with senescence.
1.Introduction
The in vitro ageing of human diploid ﬁbroblasts (HDFs),
ﬁrst described by Hayﬂick and Moorhead [1], has become
a classical experimental model to study cellular ageing.
HDFs have a limited ability to divide when cultured in
vitro. Normally after about 50 cell divisions, HDFs enter a
state of irreversible proliferative arrest, termed as replicative
senescence or cellular senescence [1].
Cells with less than 10 passages were considered
young cells with high proliferative ability while cultures
at 10–20 passages have entered an intermediate state or
pre-senescence, and cultures of over 25 passages with no
detectable doubling in cell numbers for 2 weeks were
considered as senescent cells [2]. Senescent cells have been
shown to accumulate with age in human tissues and, thus,
have been suggested to contribute to organismal ageing [3].
Reactive oxygen species (ROS) were implicated in
replicative senescence and ageing [4]. During physiological
metabolism, endogenous ROS which include superoxide
anion,hydrogenperoxide,hydroxylradicals,andsingletoxy-
gen are constantly generated in most cells. High level of ROS
can cause damage to proteins, lipids, and DNA [5]. Accu-
mulation of oxidatively damaged cellular macromolecules is
suggested to account for the free radical theory of ageing.
Upon entering the state of senescence, cells undergo
dramatic changes in morphology. The cell size or volume
is increased with accumulation of cellular debris and
intracellular vesicles, many of which are lysosomes. It
has been reported that senescent ﬁbroblasts became
ﬂattened and more irregular in shape [6] with increased
expression of senescence marker such as senescence
associated β-galactosidase (SA-β-gal). Both in vitro and in
vivo studies have shown the increase in percentage of cells2 Journal of Biomedicine and Biotechnology
positive for SA-β-gal with cumulative population doublings
(CPDs) and age [7]. Nevertheless, the mechanisms that are
responsible for the continuous cell growth and increased
in SA-β-gal expression in senescent cells have not been well
elucidated [8].
Ageing cells accumulate DNA damage which may conse-
q u e n t l yl e a dt oa ni r r e v e r s i b l eg r o w t ha r r e s t[ 9]. Cell cycle
checkpoints sense damage of the DNA structure and elicit
complex cellular repair response. The checkpoints maintain
cell cycle arrest while the repair takes place followed by cell
cycle progression once repair is completed. Cells undergo
permanent cell cycle arrest and apoptosis if the DNA cannot
be repaired adequately. A permanent cell cycle arrest occurs
with cells remaining in G0/G1 phase during senescence
[10].
Besides oxidative DNA damage accumulation, telomere
shortening has been widely considered as another important
mechanism to trigger replicative senescence in human
ﬁbroblasts. Signiﬁcant telomere shortening occurred as a
consequence of prolonged H2O2 treatment but not in acute
treatment [4]. Recently, studies by von Zlignicki et al.
[11] showed that telomere shortening was largely depen-
dent on the interplay of oxidative stress and antioxidant
defence rather than the cell divisions. A comparison of
the telomere shortening rates in diﬀerent HDFs under
diﬀerent conditions revealed that the ratio between oxidative
damage and antioxidative defence was quantitatively the
most important determinant of telomere shortening [12].
To prevent progressive DNA loss with subsequent rounds of
DNA replication, many cells maintain their telomeres by the
actionoftelomerase,aspecializedRNA-proteincomplexthat
uses its RNA component as a template for the extension of
the telomere by its reverse transcriptase subunit [13].
Inthe absenceofan adequaterepair system,accumulated
DNA damage caused mutagenic alterations resulting in
cancer, ageing, and abnormalities in the nervous system
[14]. Accumulating evidence demonstrated that vitamin E,
the most potent lipid peroxyl radical scavenger, signiﬁcantly
reduced free radical-induced chromosomal damage [15].
Vitamin E has been shown to reduce H2O2-induced OH•
generation and subsequent DNA base pair modiﬁcation in
human oral epithelial cells [16]a n dH 2O2-induced DNA
strand breaks in human skin cell line VH10 [17]. Measure-
ment of DNA repair ability tested in lymphocytes indicated
that vitamin E increased the removal rate of damaged DNA
compared to cells that are not treated with vitamin E
[18].
Natural vitamin E comprises of eight diﬀerent isomers;
they are α-, β-, γ-, and δ-tocopherols and α-, β-, γ-, and
δ-tocotrienols [19]. Based on its lipophilicity, vitamin E
is considered to be the major chain-breaking antioxidant
preventing the propagation of oxidative stress, especially
in biological membranes [20]. Vitamin E speciﬁcally α-
t o c o p h e r o lh a sb e e nr e p o r t e dt ob ea b l et om o d u l a t es i g n a l
transduction and gene expression via its antioxidant and
non-antioxidant properties [19].
Recently, the diﬀerent isomers of tocotrienol have gained
increasing scientiﬁc interest due to their eminent antioxidant
eﬀectsandanon-antioxidantactivityproﬁlethatdiﬀersfrom
tocopherols[20].Tocotrienolsarefoundinabundanceinrice
bran,palmoil,oat,andbarley[21].Tocotrienol-richfraction
consists of α-tocopherol and four isomers of tocotrienols
(α, β, γ,a n dδ), all of which are potent membrane-soluble
antioxidants [22].
The diﬀerences in the properties of tocotrienol have
suggested protective eﬀects in diseases such as cardiovascular
disease and cancer in experimental animals [23]. In an
animal model of ageing, tocotrienol extended lifespan by
19% while reducing protein carbonylation, a particularly
toxic oxidation process indicative of ageing [24]. Since
oxidants contribute to the ageing process and ageing-related
diseases in many species, possible protection from ageing by
antioxidants such as tocotrienol and tocopherol is suggested.
Even though beneﬁcial eﬀects of vitamin E have been
established in ageing [25], ongoing studies are being done
to determine mechanisms involved and actual response of
diﬀerent stages of cellular ageing. In view of this, this
study was designed to evaluate the molecular mechanism
of tocotrienol-rich fraction in possibly modulating diﬀerent
stages of cellular ageing in HDFs by determining the changes
in molecular markers of cell-ageing SA-β-gal, DNA damage,
telomere shortening, and cell cycle progression in young,
presenescent, and senescent HDFs.
2.MaterialsandMethods
2.1. Cell Culture and the Induction of Senescence. This
research has been approved by the Ethics Committee of
National University of Malaysia (Approval Project Code: FF-
218-2008). Primary HDFs were derived from the foreskins
of three 9- to 12-year-old boys after circumcision. Writ-
ten informed consents were obtained from parents of all
subjects. The samples were aseptically collected and washed
severaltimeswith75%alcoholandphosphatebuﬀeredsaline
(PBS) containing 1% antibiotic-antimycotic solution (PAA,
Austria). After removing the epidermis, the pure dermis
was cut into small pieces and transferred into a falcon tube
containing 0.03% collagenase type I solution (Worthington
Biochemical Corporation, USA). Pure dermis was digested
in the incubator shaker at 37◦C for 6–12h. Then, cells were
rinsed with PBS before being cultured in Dulbecco Modiﬁed
Eagle Medium (DMEM) containing 10% fetal bovine serum
(FBS)(PAA,Austria)and1%antibiotic-antimycoticsolution
at 37◦Ci n5 %C O 2 humidiﬁed incubator. After 5–6 days, the
cultured HDFs were harvested by trypsinization and culture-
expand into new T25 culture ﬂasks (Nunc, Denmark) with
expansion degree of 1:4. When the subcultures reached 80–
90% conﬂuence, serial passaging was done by trypsiniza-
tion and the number of population doublings (PDs) was
monitored until HDFs reached senescence. For subsequent
experiments, cells were used at either passage 4 (young cell,
population doubling; PD < 12), passage 15 (presenescent
cell, 30 < PD < 40), andpassage 30 (senescentcell,PD > 55).
2.2. Eﬀects of Various Concentrations of TRF on Cell Viability.
Cell viability study was performed using MTS assay. Brieﬂy,
stock solutions of TRF Gold Tri E 50 (Golden Hope BioganicJournal of Biomedicine and Biotechnology 3
Sdn Bhd, Malaysia) was freshly prepared in 100% ethanol
(1:1) and kept at −20◦C for not more than one month.
Immediately before use, TRF was incubated with FBS
overnight at 37◦C. Serial dilutions of TRF at concentrations
of 0.1, 0.2, 0.3, 0.4, and 0.5mg/mL were prepared in culture
medium mixed with 50% ethanol (1:1). Cells were plated
at 2 × 104 in 96-well plate and incubated overnight. Then,
the medium was replaced with new medium containing the
various concentrations of TRF and incubated for 24h at
37◦C, in 5% CO2. After incubation, 20μLM T Sw a sa d d e d
and cells were further incubated for 2h. The absorbance
of MTS formazan formed was measured at 490nm with a
microtiter plate reader (VeraMax Molecular Devices, USA).
The viability assay was performed to obtain the optimum
dose of TRF treatment for subsequent experiments. In the
subsequent experiments, treated HDFs were incubated with
0.5mg/mL TRF for 24h while untreated cells were cultured
in Dulbecco Modiﬁed Eagle Medium (DMEM) containing
10% fetal bovine serum (FBS) (PAA, Austria). The media
for the untreated cells was changed in parallel to the treated
cells. Both untreated and treated cells were harvested on the
same day.
2.3. Morphology Analysis and Senescence-Associated β-Gala-
ctosidase (SA-β-gal) Staining. HDFs positive for SA-β-gal
activity was determined as described by Dimri et al. [7].
SA-β-gal staining was performed with a senescent cell
staining kit (Sigma, USA) according to the manufacturer’s
instructions. A total of 1 × 105 cells in the TRF-treated and
control groups were seeded in six-well plates and incubated
withﬁxationbuﬀer(2%formaldehyde/0.2%glutaraldehyde)
for 6–7mins at room temperature. Cells were then rinsed
three times with PBS and incubated with 5-bromo-4-chloro-
3-indolyl β-D-galactopyranoside at 1mg/mL in a buﬀer
containing 40mM citric acid/phosphate (pH 6.0), 5mM
K3FeCN6,5m MK 4FeCN6, 150mM NaCl, and 2mM MgCl2
for 4h at 37◦C in the absence of CO2. Blue staining was visi-
bleafterincubation,andthepercentageofbluecellsobserved
in 100 cells under a light microscope was calculated.
2.4. Estimation of Telomere Length. Genomic DNA was
isolated using Wizard Genomic Puriﬁcation Kit (Promega,
USA). The DNA samples were processed separately for each
treatment. Telomere assay was performed using TeloTAGGG
Telomere Length Assay kit (Roche, USA) that determined
telomere length using terminal restriction fragment prin-
ciple. Three μg of DNA was digested with 20 units each
of HinfIa n dRsaIf o r2 ha t3 7 ◦C. Complete cutting is
conﬁrmed by electrophoresis of the DNA digests on 0.8%
agarose gel. Fractionated DNA fragments were transferred
to nylon membranes Hybond-N+ (Amersham, UK) by
an alkaline transfer technique using capillary blotting.
The blotted DNA fragments were hybridized to a digox-
igenin (DIG)-labeled probe speciﬁc for telomeric repeats
(TTAGGG) for 3h at 42◦C with gentle agitation with a DIG-
speciﬁc antibody covalently coupled to alkaline phosphatase.
Finally, the immobilized telomere probe was visualized
by alkaline phosphatase metabolizing CDP-Star, a highly
sensitive chemiluminescence substrate. The average terminal
restriction fragment length was determined by comparing
signals relative to a nuclear weight standard on X-ray ﬁlm.
The average terminal restriction fragment length of each
sample was obtained by scanning the exposed X-ray ﬁlm and
quantifying using ImageMaster Total lab software.
2.5. Estimation of Telomerase Activity. Detection of telom-
erase activity using the telomeric repeat ampliﬁcation pro-
tocol (TRAP) in cultured cells involves the addition of
TTAGGG repeats by telomerase to an oligonucleotide (TS)
and the subsequent PCR ampliﬁcation of these extension
products with both the forward (TS) and reverse (CX)
primers. The TRAPeze telomerase detection kit (Chemicon,
USA) was used as recommended by the manufacturer with
minor modiﬁcations [26]. Brieﬂy, cell pellets were stored at
−80◦C until lysis was performed. The lysis buﬀer contained
1% Nonidet P-40 and 0.25mM sodium deoxycholate to
increasetheeﬃciencyofextraction.Cellswerelysed,thenleft
on ice for 30min, and centrifuged at 14,000g for 20min at
4◦C. The supernatant was ﬂash-frozen and stored at −80◦C.
The extracted protein concentration was determined from
bovine serum albumin (BSA) standard plot of OD595 versus
μg BSA based on Bradford method. For the PCR reaction,
500ng/μL of protein was needed. The total counts in the
sample was added to 48μL reaction mixture and 2 units of
Taq DNA polymerase (Promega, USA). After incubation at
room temperature for 30min for the telomerase extension
reaction, samples were heated to 92◦C for 3min to inactivate
telomerase followed by PCR ampliﬁcation. PCR products
wereelectrophoresed on 10% polyacrylamide gel, and the gel
was further analysed and quantitated using the ImageMaster
Total lab software. Telomerase activity was calculated as the
ratio of the intensity of telomerase ladders to the intensity of
the 36-bp internal standard.
2.6. Determination of DNA Damage. DNA damage was
assessed using single-cell gel electrophoresis assay (SCGE;
Comet assay). The alkaline version of Comet assay was
performed according to the method described by Singh
et al. [27]. Frosted microscope slides were prepared with
105μL of normal melting agarose. Cells were embedded
in 65μL 0.6% low-melting point agarose layer (Boehringer
Mannheim,Germany)(DNAsefree,RNAsefree)onagarose-
coated frosted slides. The cells were lysed in a buﬀer
containing 2.5M NaCl, 100mM EDTA, 10mM Tris, 1% N-
laurylsarcosine, 1% Triton, and 2% dimethylsulphoxide, at
pH 10, for 1h at 4◦C. Thereafter, the cells were exposed
to a strong alkaline solution (300mM NaOH, 1mM EDTA,
pH 13) for 25min in an electrophoresis chamber. Elec-
trophoresis was performed for 20min at 25V and 200mA.
The slides were then neutralized (0.4M Tris, pH 7.5) and
stained with ethidium bromide (20μg/mL). Comets were
analysed by ﬂuorescence microscopy (Carl Zeiss, Germany)
with visual inspection of tail length of nuclei. The cell nuclei
were classiﬁed into ﬁve categories: (0) undamaged (nuclei
withoutcomettail),(1)lowdamaged(nucleiwithcomettails
up to two fold longer than nucleus diameter), (2) damaged
(nuclei with comet tail two to three-fold longer than nucleus
diameter), (3) highly damaged (nuclei with comet tails three4 Journal of Biomedicine and Biotechnology
foldlongerthannucleusdiameter),and(4)severelydamaged
(cell nuclei was almost not visible with long and dispersed
comettails).Atleast300cellsperslidewerecounted,andtwo
slideswerepreparedforeachtreatment.Atotaldamagescore
was determined by multiplying the number of cells assigned
to each grade of damage by the numeric value of the grade
according to methods describe by Heaton et al. [28]. Total
D N Ad a m a g es c o r ew a sc a l c u l a t e da sf o l l o w s :
Total DNA damage = [(0 × n0)+(1 ×n1)+(2 × n2)
+(3 ×n3)+(4 ×n4)],
(1)
where n0 = cells with score 0, n1 = c e l l sw i t hs c o r e1 ,n2 =
cells with score 2, n3 = cells with score 3, and n4 = cells with
score 4.
2.7. Cell Cycle Analysis. Untreated control and TRF-treated
HDFs were subcultured in 10cm2 tissue culture dishes.
After 24h incubation, cells were harvested and prepared
usingCycleTESTPLUSDNAReagentKit(BectonDickinson,
USA) according to the manufacturer’s instruction. Cell cycle
status was analyzed by FACS Caliber ﬂow cytometer (Becton
Dickinson, USA) using propidium iodide (PI) as a speciﬁc
ﬂuorescentdyeprobe.ThePIﬂuorescenceintensityof10,000
cells was measured for each sample.
2.8. Statistical Analysis. Each experiment was carried out
in triplicates with at least 3 independent cultures with
comparable results. Data are reported as mean ± SD of at
least three experiments. Comparison between groups were
made by ANOVA and Student’s t-test (two-tailed). P<. 05
was considered statistically signiﬁcant.
3. Results
3.1. Dose Response Curve of TRF in Cultured HDFs. Figure 1
shows the percentage of viable ﬁbroblast cells after incubated
with TRF at various concentrations (0.1–0.5mg/mL) for
24h.Thepercentageofviablecellswassigniﬁcantlyincreased
(P<. 05) with TRF treatment at 0.5mg/mL (Figure 1(a))
for young HDFs. For presenescent HDFs, the percentage of
viable cells was signiﬁcantly increased (P<. 05) with TRF
incubation at concentrations of 0.3mg/mL, 0.4mg/mL, and
0.5mg/mL (Figure 1(b)) while the percentage of viable cells
forsenescentHDFswassigniﬁcantlyincreased(P<. 05)with
TRF treatment at all concentrations (Figure 1(c)). Therefore,
TRF at concentration 0.5 μg/mL was used for the subsequent
experiments for all types of HDFs.
3.2. Cell Morphology and SA-β-Galactosidase Expression.
Morphological changes were observed with ageing of the
HDFs. Young HDFs displayed the normal spindle shape
characteristic of ﬁbroblast cells. However, with senescence,
the original ﬁbroblastic shape was lost and HDFs became
larger and ﬂattened with accumulation of cytoplasmic
granular inclusions (Figures 2(a)–2(c)). The morphology of
TRF-treated HDFs resembled that of young cells with more
spindle shaped cells present (Figures 2(d)–2(f)).
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Figure 1: Dose response of tocotrienol-rich fraction (TRF) on
young (a), presenescent (b), and senescent (c) HDFs after 24h
incubation at 37◦C. Incubation with TRF caused a signiﬁcant
increase in the viability of HDFs. aDenotes P<. 05 compared
to control, bP <. 05 compared to lower concentration. Data are
presented as mean ± SD, n = 9.
Positive blue stain of SA-β-gal appeared mainly in HDFs
at passage 30 suggesting the presence of senescent cells
(Figure 3). Quantitative analysis showed the percentage of
cells positive for SA-β-gal staining was increased (P<. 05) in
senescent cells compared to young and presenescent HDFs.
Incubation of senescent cells with 0.5mg/mL TRF signiﬁ-
cantly decreased (P<. 05) the percentage of positive SA-β-
gal stained cells compared to untreated control (Figure 4).
3.3. Eﬀe c to fT R FT r e a t m e n to nD N AD a m a g ea n dC e l lC y c l e
Progression. Damaged DNA was higher in senescent HDFs
compared to young and presenescent cells (P<. 05) which
was decreased with TRF-treatment (P<. 05) (Figure 5). Cell
cycle progression analysis showed that the cell population
in the S phase was lower (P<. 05) in senescent HDFs
compared to young HDFs. Treatment with TRF signiﬁcantly
increased (P<. 05) cells in the S phase and G2/M phaseJournal of Biomedicine and Biotechnology 5
(a) (b) (c)
(d) (e) (f)
Figure 2: Morphological changes of HDFs in culture. Young (a), presenescent (b), and senescent (c) HDFs compared to TRF-treated HDFs
(d)–(f). Senescent HDFs lost their original ﬁbroblastic shape by acquiring a ﬂattened morphology (indicated by arrow) with increased
in size of nucleus and cells. The morphology of TRF-treated HDFs resembled that of young cells with more spindle-shaped cells present.
Micrographs are shown at 200x magniﬁcation.
for all stages of cellular senescence of HDFs. In contrast, cell
populations in G0/G1 phase decreased signiﬁcantly (P<. 05)
with TRF treatment in young, presenescent, and senescent
HDFs (Figure 6).
3.4. Eﬀect of TRF Treatment on Telomere Length and
Telomerase Activity. Figure 7(a) shows the representative
Southern blot analysis of HDFs at various passages with TRF
treatment. Shortening of telomere length were observed with
senescence of HDFs. Telomere length in senescent HDFs
was signiﬁcantly decreased compared to untreated young
HDFs (P<. 05). Protective eﬀe c t so fT R Fa g a i n s tt e l o m e r e
shortening was observed in senescent HDFs. Similar TRF
treatment had no eﬀect on telomere length in young HDFs
(Figure 7(b)).
Figure 7(c) shows the representative PCR analysis for
telomerase activity of HDFs at various passages with
TRF treatment. Similarly, protection against loss of telom-
erase activity was observed in senescent HDFs. Treatment
with TRF signiﬁcantly increased the telomerase activity in
senescent HDFs (P<. 05) whereby no eﬀects was observed
in young HDFs (Figure 7(d)).
4. Discussion
The present study evaluated the eﬀects of tocotrienol-rich
fraction (TRF) in possibly modulating cellular ageing in
HDFs. Our results showed that when HDFs reached senes-
cence,therewereclearchangesincellmorphology,decreased
cell proliferation and increased senescence associated β-
galactosidase activity. Typical morphology of senescent
cells observed in this study has also been reported with
multiple passages of cells [29]. Granular cytoplasmic and
vacuoles accumulation are common features of senescent
cells accounting for the large cells [16]. Senescent cells
are also ﬁlled with large and numerous lysosomes that
contain hydrolytic enzymes which function in ingesting and
digesting organelles that are aged or damaged [30].
The biomarker SA-β-gal can distinguish senescent cells
from quiescent cells. The increased SA-β-gal positive cells6 Journal of Biomedicine and Biotechnology
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Figure 3: β-Galactosidase staining in young (a), presenescent (b) and senescent HDFs (c) compared to TRF-treated HDFs (d)–(f). Positive
blue stain of SA-β-galactosidase appeared in senescent HDFs as indicated by arrow. Micrographs are shown at 200x magniﬁcation.
which was observed with senescence of HDFs can be
attributed to increased in lysosomal content [31]. Increased
autophagy may be associated with an increase in lysosomal
mass and SA-β-gal in in vitro ageing [32]. In addition, it
is possible to ﬁnd a correlation between the increase in
SA-β-gal and appearance of the senescent morphotypes.
Increase in SA-β-gal activity in senescent HDFs and
stress-induced premature senescence (SIPS) is an irreversible
process upon subculture, suggesting that cellular ageing
results in irreversible nonmitotic growth [33]. However,
incubation with TRF was shown to decrease the percentage
of cells positive for SA-β-gal suggesting a reversal of cellular
ageing of HDFs. In addition, TRF-treated HDFs displayed a
reduction in senescence characteristics. This eﬀect is possibly
due to the antioxidant property of TRF which consists
of α-tocopherols and all isomers of tocotrienols. Previous
study has shown that tocotrienols have high antioxidant
activity and that the uptake of tocotrienols from the
culture medium by cultured cells was more eﬃcient than
tocopherols. Tocotrienol can penetrate rapidly through skin
and eﬃciently combat oxidative stress [34].
Our data on cells viability study showed TRF treatment
increased the percentage of viable cells with increasing
concentrations of TRF. The percentage of viable cells was
highest at the maximum concentration studied, that is,
0.5mg/mL indicating TRF promoted cells propagation and
viability in all stages of cellular ageing of HDFs.
Oxidative stress caused damage to DNA which increased
signiﬁcantly in senescent cells, especially in postmitotic
tissues and the levels correlated with ageing and age-related
diseases[35].Taharaetal.reportedthatage-relatedincreased
in the levels of oxidative DNA base damage was a signiﬁcant
contributor to many age-related pathological diseases. If
accumulation of damaged DNA exceeds its elimination by
DNA repair mechanism, cellular senescence, or apoptosis
takes place and contributes to the ageing process [36].
Comet assay allows visualization of damaged DNA in
individual cells. Comparison of damaged DNA in diﬀerent
treatment groups of HDFs in the present study showed that
total DNA damage was signiﬁcantly increased in senescent
cells while less damaged DNA was observed in young and
presenescent HDFs. ROS caused chronic and persistent
damage to DNA, causing double strand breaks that remain
unrepaired which tend to accumulate in senescent cells
indicating a possible cause of ageing in mammals [37].
Increased in ROS-induced DNA damage was reported to
be correlated with cell cycle arrest [38]. Similarly, our data
showed signiﬁcant decreased in S phase cells and increased
in damaged DNA in senescent HDFs indicating less cell
proliferation and greater DNA damage as cells aged.
ItishighlyprobablethatprotectionagainstDNAdamage
withTRFtreatmentinsenescentHDFscouldbeattributedto
either prevention of oxidative stress-induced DNA damage
or enhancement of DNA repair mechanism. Vitamin E,
particularly α-tocopherol, has been suggested to inhibit acti-
vation of endonuclease that can be triggered by intracellular
oxidative stress and enhanced DNA repair by increasing
the rate of removal of damaged DNA [18]. Previous studyJournal of Biomedicine and Biotechnology 7
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Figure 4: Quantitative analysis of positive β-galactosidase stained
cells in HDFs duringcellular ageing. Thepercentage ofcells positive
for SA-β-gal staining was signiﬁcantly increased in senescent cells.
Incubation of senescent cells with TRF signiﬁcantly decreased the
percentage of cells positive for SA-β-gal staining. aDenotes P<. 05
compared to untreated young HDFs, and bP <. 05 compared to
untreated presenescent HDFs, cP <. 05 compared to untreated
senescent HDFs, dP <. 05 compared to treated young HDFs, eP <
.05 compared to treated presenescent HDFs. Data are presented as
mean ± SEM, n = 6.
reported that vitamin E reduced H2O2-induced HO• gener-
ation and subsequent DNA base pair modiﬁcation in human
oral epithelial cells [16] besides decreasing H2O2-induced
DNA strand breaks in human skin cell line VH10 [17].
Cellular senescence in response to DNA damage or
degradation would make the cells’s progeny nonviable and
might indicate a decline in renewal capability of cells as
they reach an irreversible growth arrest. Growth-arrested
cells were predominantly seen in G1 or G2/M phase. Our
data showed no signiﬁcant diﬀerence in G0/G1 or G2/M
phase with cellular ageing of HDFs, while the S phase cells
decreased signiﬁcantly. The reduction in S phase cells with
senescence can be attributed to slow rate of proliferation
as cells undergoing ageing. This process, however, was
reduced by TRF treatment. The decreased and increased cells
in G0/G1 phase and S phase, respectively, were observed
with TRF treatment at various stages of cellular ageing
indicating inhibition of growth arrest and enhancement of
cell replication. This observation indicated TRF was able
to promote cell progression, and increased cells replicative
capacity. Decreased level of total DNA damage and increased
percentage of cells in S phase in TRF-treated senescent cells
indicated a potential protective role of TRF against DNA
strand breaks and cell cycle arrest.
One of the mechanisms mediating the development of
the senescent phenotype is telomere shortening. It has been
clearly demonstrated that cell replication caused telomere
shortening due to the inability of DNA polymerase to
completely replicate the 3 -ends of lagging strands in the
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Figure 5: Comparison of total DNA damage at various stages
of cellular ageing measured by Comet assay. Damaged DNA was
higherinsenescentHDFswhichwasdecreasedwithTRFtreatment.
aDenotes P<. 05 compared to untreated young HDFs, bP <. 05
compared to untreated presenescent HDFs, cP <. 05 compared
to untreated senescent HDFs, dP <. 05 compared to TRF-treated
young HDFs. Data are presented as mean ± SD, n = 6.
majority of normal human somatic cells which lack telom-
erase activity [39]. Our data in the present study suggested
that both telomere shortening and decreased telomerase
activity might be the contributing factors in cellular ageing.
It has been reported that due to inherent limitations in the
mechanics of DNA replication, telomeres shorten at each cell
division, and in the absence of telomerase, when telomere
shortening reaches a critical limit, cells are susceptible to
chromosomal aberrations such as end-to-end fusion and
aneuploidy. In such a situation, the cells cease to divide
and reach replicative senescence [40]. Treatment with TRF,
however, protected against telomere shortening in senescent
HDFs with concomitant increased in telomerase activity.
Our previous study had shown that both γ-tocotrienol
and α-tocopherol protected against oxidative stress-induced
telomere shortening in HDFs derived from diﬀerently aged
individuals.Therestorationoftelomeraseactivityinducedby
α-tocopherol caused signiﬁcant increased in telomere length
especiallyinskinﬁbroblastobtainedfromolddonor[26,41].
In summary, TRF treatment exerted better protection
in senescent HDFs when compared to young and presenes-
cent HDFs. Possibly higher requirement for antioxidants is
indicated in senescent HDFs as the uptake of TRF and its
utilization in senescent HDFs is enhanced for protection
against ROS related damage. Similar protective eﬀects may
not be required for young and presenescent HDFs.
Therefore, we concluded that tocotrienol-rich fraction
delays or prevents cellular ageing particularly in senescent
HDFs as shown by the elongated telomere length, decreased8 Journal of Biomedicine and Biotechnology
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Figure 6: Analysis of cell cycle progression. Flow cytometric analysis of cell cycle progression in young, presenescent, and senescent HDFs
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Figure 7: Eﬀects of tocotrienol-rich fraction (TRF) on telomere length and telomerase activity. Representative Southern blot analysis of
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2: positive control DNA, lane 3: untreated young HDFs, lane 4: TRF-treated young HDFs, lane 5: untreated presenescent HDFs, lane 6:
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levels of damaged DNA, and progression of cell cycle to
S phase besides increased cell propagation in all stages of
cellular ageing of HDFs with TRF treatment.
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